$23.50
+0.02 (+0.09%)
Open$23.48
Previous Close$23.48
Day High$23.50
Day Low$23.48
52W High$23.50
52W Low$8.61
Volume—
Avg Volume350.4K
Market Cap151.86M
P/E Ratio—
EPS$-5.73
SectorPharmaceuticals
Analyst Ratings
Buy
10 analysts
Price Target
+2.0% upside
Current
$23.50
$23.50
Target
$23.96
$23.96
$13.92
$23.96 avg
$25.97
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 119.81M | 131.28M | 46.50M |
| Net Income | -30,655,937 | -30,232,679 | 11.15M |
| Profit Margin | -25.6% | -24.3% | 24.0% |
| EBITDA | 255.3K | 265.7K | 17.15M |
| Free Cash Flow | — | — | 10.93M |
| Rev Growth | -8.7% | -8.7% | +24.8% |
| Debt/Equity | 0.42 | 0.42 | 0.73 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |